Browse our catalogue of products
73 products displayed
Ref-SKU | Type | Product | Description | ICTV Taxonomy | Virus name | Strain | Isolate | Product Grading | Availability | Product Risk Group | Provider | Cost per Access (Academics) | More info | Add to Cart |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
006S-05710 | Service | Upon request virus stock production in a single batch under BSL2 conditions | Virus production of viruses available on the EVAg catalogue from BMC-SAS in a single batch upon request containing 30 cryotubes containing 0.5mL. | Viruses | Any virus | Upon request | RG2 | BMC-SAS | 9,000€ | View all details on this product . . . | Free access available | |||
021S-05405 | Service | APHA - Training Course: Diagnostic tools for Bovine Leukemia (Leukosis) Virus | This four day course will go through the general principles for the diagnosis of bovine leukemia virus, through a combination of discussions, demonstrations and hands-on training. The training will include sample processing, PCR, ELISA (serology), reagent production, virus related bio-safety and diagnostic quality systems. | Bovine leukemia virus | Bovine leukemia virus | In stock | RG2 | DEFRA | 5,000€ | View all details on this product . . . | Free access available | |||
024A-05001 | Antibody or Hybridoma |
Porcine anti-Japanese encephalitis virus polyclonal antiserum
Reference Strain |
Hyperimmune polyclonal antiserum raised in a domestic pig challenged with Japanese encephalitis virus (JEV) Nakayama strain and boosted 47 days later. Serum was collected at day 83 post primary challenge. | Japanese encephalitis virus | Japanese encephalitis virus | Nakayama | Bronze | In stock | RG2 | CSIRO | 500€ | View all details on this product . . . | Free access available | |
014S-05230 | Service | Access to RIVM infrastructure to use anonymized Norovirus patient material for experiments of choice | Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strains, representing different genotypes. Strains/genotypes/year (2012-2023) selection on demand. Custom-made package includes individual fecal material from 5 different patients, 10-20% suspended in virus culture medium. Service includes technical input on protocols and experiment design and support in the laboratory. Individual questions to refine potential requests can be sent to RIVM-EVAglobal@rivm.nl. | Norovirus | Norovirus | Upon request | RG2 | RIVM | 5,000€ | View all details on this product . . . | Free access available | |||
014S-05231 | Service | Access to RIVM infrastructure to use anonymized Sapovirus patient material for experiments of choice | Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced sapovirus strains, representing different genotypes. Strains/genotypes/year (2012-2023) selection on demand. Custom-made package includes individual fecal material from 2 different patients, 10-20% suspended in virus culture medium. Service includes technical input on protocols and experiment design and support in the laboratory. Individual questions to refine potential requests can be sent to RIVM-EVAglobal@rivm.nl. | Sapovirus | Sapovirus | Upon request | RG2 | RIVM | 5,000€ | View all details on this product . . . | Free access available | |||
027N-05015 | Nucleic Acid |
Plum pox virus (PPV), Potyvirus, infectious cDNA clone
Reference Strain |
Infectious cDNA clone of PPV DSMZ PV-0001, cloned into pDIVA vector under control of the 35S promoter, infectivity tested on N.benthamiana | Plum pox virus | Plum pox virus | DSMZ PV-0001 | Gold | In stock | RG2 | DSMZ | 300€ | View all details on this product . . . | Free access available | |
027N-05014 | Nucleic Acid |
Tomato bushy stunt virus (TBSV), Tombusvirus, infectious cDNA clone
Reference Strain |
Infectious cDNA clone of TBSV DSMZ PV-0268, cloned into pDIVA vector under control of the 35S promoter, infectivity tested on N.benthamiana | Tomato bushy stunt virus | Tomato bushy stunt virus | DSMZ PV-0268 | Gold | In stock | RG2 | DSMZ | 300€ | View all details on this product . . . | Free access available | |
010S-04799 | Service | Principles and practice of virus neutralization assays | Virus Neutralization Tests (VNT), also including plaque-reduction and foci-inhibition assays like PRNT and RFFIT, are the gold standard for determining antibody titers against viruses, and are essential serological tools. In this 5-day training the application and basic principles of VNTs will be discussed, and will be combined with wet lab training. The wet lab training will include all steps of the VNT, including analysis and interpretation of the results. The training will be provided on demand and can be designed for the following viruses: rabies virus (RABV), SARS-CoV-2, Zika virus, yellow fever virus and other flaviviruses, All lectures and lab training will be targeted to the virus of interest. After this training participants should have sufficient knowledge to establish VNTs in their own laboratory. | Viruses | Any virus (see additrional information) | Upon request | RG2 | ERASMUS-MC | 1,500€ | View all details on this product . . . | Free access available | |||
006N-01987 | Nucleic Acid |
pHIV-1_pr45I-47V-50V
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 (NL4-3) with the respective specific mutations in the protease gene. These may confer drug resistance to specific HIV protease inhibitors and have been identified in clinical specimens from individuals with therapeutic failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | recombinant | Platinum | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available | |
006N-02608 | Nucleic Acid |
pHIV-1_pr63P-71V-82T-84V
Antiviral resistant strain |
Protease mutant with discrete mutations relevant for drug resistance to protease inhibitors | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Clade B | Platinum | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available | |
007N-04416 | Nucleic Acid |
pHIV-1_gp41-MIF
Reference Strain |
Gp41 recombinant, carrying the "MIF" motif, typical for subtype AE, in the fusion domain of the subtype B prototype NL4-3 - for studying the fusion function. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Clade B | Platinum | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available | |
006N-00921 | Nucleic Acid | pNL-NF HIV-1 | full length plasmid clone of proviral HIV-1; construct produces infectious HIV-1 upon transfection into eukaryotic cells | Human immunodeficiency virus 1 | Human immunodeficiency virus type 1 | subtype B | derivative of HIV-1 NL4-3 | Platinum | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
006N-03078 | Nucleic Acid |
pHIV-1_rt-D67N
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with specific mutations in the reverse transcriptase gene, which can confer drug resistance to specific HIV-1 inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on reverse transcriptase inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Platinum | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
006N-03079 | Nucleic Acid |
pHIV-1_rt-K103N
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with specific mutations in the reverse transcriptase gene, which can confer drug resistance to specific HIV-1 inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on reverse transcriptase inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Platinum | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
006N-03080 | Nucleic Acid |
pHIV-1_rt-M184V
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with specific mutations in the reverse transcriptase gene, which can confer drug resistance to specific HIV-1 inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on reverse transcriptase inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Platinum | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
006N-03084 | Nucleic Acid |
pHIV-1_pr-L33F
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with specific mutations in the protease gene, which can confer drug resistance to specific HIV-1 PR inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on PR inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Platinum | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
006N-03072 | Nucleic Acid |
pHIV-1_pr-V82A
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with specific mutations in the viral protease gene, which can confer drug resistance to specific HIV-1 protease inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on protease inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Platinum | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
006N-03073 | Nucleic Acid |
pHIV-1_pr-L63P
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with a specific mutation in the protease gene, which has been described as a polymorphic mutation. It is unclear, whether it can confer drug resistance to specific HIV-1 PR inhibitors directly. It has been shown in cell culture that the presence of the 63P change leads to higher "replicative fitness" of the virus. The respective mutations have been reported in viruses from HIV-infected individuals on PR inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Platinum | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
006N-03074 | Nucleic Acid |
pHIV-1_pr-L90M
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with specific mutations in the protease gene, which can confer drug resistance to specific HIV-1 PR inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on PR inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Platinum | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
006N-03082 | Nucleic Acid |
pHIV-1_pr-M46I
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with specific mutations in the protease gene, which can confer drug resistance to specific HIV-1 PR inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on PR inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Platinum | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
006N-02591 | Nucleic Acid | pHIV-1_gp41_F8Y-T18I-A21C-A22T | clonal spontaneous in vitro revertant of a gp41 mutant with a discrete mutation in the gp41-fusion domain "LFLGFL" | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Clade B | Platinum | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available | |
006N-02575 | Nucleic Acid |
pHIV-1_pr84V
Antiviral resistant strain |
HIV-1, drug resistant point mutant of protease, selected by specific HIV protease inhibitors. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Clade B | Platinum | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available | |
006N-02574 | Nucleic Acid |
pHIV-1_pr84A
Antiviral resistant strain |
HIV-1, drug resistant point mutant of protease, selected by specific HIV protease inhibitors in vivo | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Clade B | Platinum | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available | |
006N-02573 | Nucleic Acid | pHIV-1_pr54V | HIV-1, drug resistant point mutant of protease, selected by specific HIV protease inhibitors in vivo | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Clade B | Platinum | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available | |
006N-02572 | Nucleic Acid |
pHIV-1_pr50L
Antiviral resistant strain |
HIV-1, drug resistant point mutant of protease, reported to be specifically selected by the HIV protease inhibitor atazanavir in vivo | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Clade B | Platinum | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |